Dupuytren’s contracture: clarification of intention and amendment of the prescription
This explains why IIAC has amended its recommendation for Dupuytren's contracture as a prescribed disease for Industrial Injuries Disablement Benefit.
Documents
Details
At the request of the Department for Work and Pensions, the Industrial Injuries Advisory Council (IIAC) reviewed and amended the recommendation it made in May 2014 in ‘Dupuytren’s contracture due to hand-transmitted vibration’ to prescribe Dupuytren’s contracture as a disease for Industrial Injuries Disablement Benefit. It was always the council’s intention that the most disabling element of this condition is covered and this note clarifies the eligibility conditions.
IIAC received further feedback from key stakeholders on the prescription for Dupuytren’s contracture having previously provided additional information on 22 May 2020 on the disabling element of the disease. This updated information note provides further clarification for stakeholders on the disabling elements of the disease which are required to make a claim. It is hoped this updated information note addresses these concerns.
Updates to this page
Last updated 14 April 2023 + show all updates
-
Updated version of 'Dupuytren’s contracture: clarification of intention and amendment of the prescription'. This version provides further clarification for stakeholders on the disabling elements of the disease which are required to make a claim.
-
Updated version of 'Dupuytren’s contracture: clarification of intention and amendment of the prescription' published to provide further clarification around the involvement of the disabling element of this disease in the knuckle joints.
-
First published.